[{"title": "Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript", "url": "https://seekingalpha.com/article/4812829-journey-medical-corporation-derm-q2-2025-earnings-call-transcript", "snippet": "The content of this call contains time-sensitive information that is accurate only as of today, Tuesday, August 12, 2025. Except as required by law, Journey Medical disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call.", "published": "2025-08-12T22:42:00+00:00"}, {"title": "Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates", "url": "https://www.msn.com/en-us/money/economy/journey-medical-corporation-derm-reports-q2-loss-beats-revenue-estimates/ar-AA1KpbtX", "snippet": "Journey Medical Corporation (DERM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.", "published": "2025-08-12T21:15:01+00:00"}, {"title": "Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release", "url": "https://www.msn.com/en-us/money/general/journey-medical-corporation-derm-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q2-release/ar-AA1JSNtR", "snippet": "The market expects Journey Medical Corporation (DERM) to deliver a year-over-year increase in earnings on flat revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture,", "published": "2025-08-04T14:00:03+00:00"}, {"title": "Journey Medical outlines Emrosi launch momentum and targets expanded ...", "url": "https://seekingalpha.com/news/4448462-journey-medical-outlines-emrosi-launch-momentum-and-targets-expanded-payer-access-in-2025", "snippet": "Earnings Call Insights: Journey Medical Corporation (DERM) Q1 2025 Management View Claude Maraoui, Co-Founder, President and CEO, highlighted the Q1 2025 launch of Emrosi, describing it as \"a ...", "published": "2025-05-15T00:10:00+00:00"}]